Fig. 1

Survival of primary central nervous system diffuse large B-cell lymphoma (PCNS-DLBCL) patients stratified by the Memorial Sloan Kettering Cancer Center (MSKCC) prognostic system and by POD24 status. (A) and (B) Overall survival (OS) and Progression-free survival (PFS) curves for PCNSL patients stratified by the MSKCC prognostic system. (C) and (D) Comparison of OS between non-POD24 and POD24 groups within the study cohort and the validation dataset (the MSK dataset of the cBioPortal database).